Targeting these CSCs through EMT inducer pathways, such as TGFβ, Wnt, Notch and Hedgehog signaling pathways, may cause lasting and complete regression; this could enhance treatment outcomes for patients with RCC and improve prognosis (28). Here, TGFB1 is linked to renal cell carcinoma.